DS
Deeplaxmi Sanjeev Chitre
About Deeplaxmi Sanjeev Chitre
Data last updated:
Deeplaxmi Sanjeev Chitre has 30 years in corporate governance. Holds Director role. Currently with 1 company, including Bio-Ved Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bio-Ved Pharmaceuticals Private Limited at ₹1.01 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bio-Ved Pharmaceuticals Private Limited U24239MH1995PTC094274 | Director | 08 Nov 1995 | 1995 | ₹1.01 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deeplaxmi Sanjeev Chitre
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deeplaxmi Sanjeev Chitre
Deeplaxmi Sanjeev Chitre has 30 years in corporate governance. Holds Director role. Currently with 1 company, including Bio-Ved Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bio-Ved Pharmaceuticals Private Limited at ₹1.01 Cr (FY 2024).
Deeplaxmi Sanjeev Chitre is associated with 1 company as Director, including Bio-Ved Pharmaceuticals Private Limited (₹1.01 Cr).
Deeplaxmi Sanjeev Chitre has expertise in General Business.
Deeplaxmi Sanjeev Chitre has 30 years in corporate governance.
By reported revenue, the largest current company of Deeplaxmi Sanjeev Chitre is Bio-Ved Pharmaceuticals Private Limited, with revenue of ₹1.01 Cr (FY 2024).
Deeplaxmi Sanjeev Chitre currently holds positions at 1 company: Bio-Ved Pharmaceuticals Private Limited (₹1.01 Cr).